Attivisti tal-MGRM jinterrompu d-diskors tas-Segretarju Parl Last reply by Admin on Fri, 12 Sep 2025 07:02:29 +0000

ICYMI: Attivisti tal-MGRM jinterrompu d-diskors tas-Segretarju Parl: Last reply by Admin on Fri, 12 Sep 2025 07:02:29 +0000 #MGRM #Attivisti #Politika #Malta #Diskors

Attivisti tal-MGRM jinterrompu d-diskors tas-Segretarju Parl Last reply by Admin on Thu, 11 Sep 2025 13:13:40 +0000

ICYMI: Attivisti tal-MGRM jinterrompu d-diskors tas-Segretarju Parl: Last reply by Admin on Thu, 11 Sep 2025 13:13:40 +0000 #MGRM #Attivisti #Drittijiet #Politika #Malta

Attivisti tal-MGRM jinterrompu d-diskors tas-Segretarju Parl Last reply by Admin on Fri, 12 Sep 2025 07:02:29 +0000

Attivisti tal-MGRM jinterrompu d-diskors tas-Segretarju Parl: Last reply by Admin on Fri, 12 Sep 2025 07:02:29 +0000 #MGRM #Attivisti #Drittijiet #Politika #Malta

Attivisti tal-MGRM jinterrompu d-diskors tas-Segretarju Parl Last reply by Admin on Thu, 11 Sep 2025 13:13:40 +0000

Attivisti tal-MGRM jinterrompu d-diskors tas-Segretarju Parl: Last reply by Admin on Thu, 11 Sep 2025 13:13:40 +0000 #Attivisti #MGRM #Diskors #SegretarjuParl #Malta

Zimmer Biomet Earnings: Revenue Surges 7% to $2.1B, Acquires AI Robotics Firm as Growth Accelerates Q2 sales reach $2.1B with 7% growth, EPS rises to $2.07. Company raises full-year outlook and announces strategic AI robotics acquisition. Get full details.

#MGRM #ZBH Zimmer Biomet Announces Second Quarter 2025 Financial Results

www.stocktitan.net/news/MGRM/zimmer-biomet-...

Monogram Technologies Announces World’s First Fully Autonomous Saw-Based Robotic Knee Replacement Surgery Monogram Technologies (NASDAQ: MGRM) has achieved a historic milestone by completing the world's first fully autonomous saw-based robotic knee replacement surgery on a live patient. The groundbreaking procedure was performed on July 26, 2025, at Krishna Shalby Hospital in Ahmedabad, India, using Monogram's mBôs TKA System.The surgery is part of a 102-patient multi-center clinical trial in India, approved by CDSCO, evaluating the system's safety and effectiveness. The procedure utilized the Consensus CKS implant, which is substantially equivalent to Monogram's mPress implants. This achievement follows the recent FDA 510(k) clearance for Monogram's semi-autonomous TKA System and comes amid Zimmer Biomet's (NYSE: ZBH) pending acquisition of Monogram.

#MGRM Monogram Technologies Announces World’s First Fully Autonomous Saw-Based Robotic Knee Replacement Surgery

www.stocktitan.net/news/MGRM/monogram-techn...

#MGRM: Monogram Technologies to be Acquired by Large Medical Device Company Zimmer Biomet Holdings buff.ly/rWIFHUN

BREAKING NEWS: ( NASDAQ: #MGRM ) Monogram Technologies to Be Acquired by Zimmer Biomet in Transformational Robotics Deal

Monogram Technologies to Be Acquired by Zimmer Biomet in Transformational Robotics Deal Shares of Monogram Technologies (MGRM) surged 100% in early trading following the announcement of a definitive agreement to be acquired by Zimmer Biomet (ZBH) i

#MonogramTechnologies #MGRM to be acquired by #zimmerbiomet in a game-changing robotics deal! The move signals major momentum in surgical innovation and orthopedic tech.
prismmarketview.com/monogram-tec...

Zimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous Solutions Zimmer Biomet (NYSE: ZBH) has announced a definitive agreement to acquire Monogram Technologies (NASDAQ: MGRM) for an upfront payment of $4.04 per share, representing an equity value of approximately $177 million. The deal includes a CVR worth up to $12.37 per share tied to development milestones through 2030.The acquisition will expand Zimmer Biomet's ROSA® Robotics platform with Monogram's semi- and fully autonomous robotic technologies. Monogram's FDA-cleared CT-based, semi-autonomous AI-navigated total knee arthroplasty technology is expected to be commercialized with Zimmer Biomet implants in early 2027. The deal positions Zimmer Biomet to potentially become the first company to offer fully autonomous surgical robots in orthopedics.The transaction is expected to be neutral to adjusted EPS in 2025-2027 and accretive thereafter, with revenue growth contribution beginning in 2027. The deal is anticipated to close later in 2025, subject to regulatory and shareholder approvals.

#MGRM #ZBH Zimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous Solutions

www.stocktitan.net/news/MGRM/zimmer-biomet-...

#MGRM: The De-Risking of the Monogram Story from FDA Clearance and Initiation of Live Patient Trials Supports Price Target of $6.00 buff.ly/2mmWCmF

Monogram Technologies Reports First Quarter 2025 Financial Results Monogram Technologies (NASDAQ: MGRM) reported its Q1 2025 financial results and achieved significant milestones. The company received FDA 510(k) clearance for its mBôs™ Total Knee Arthroplasty (TKA) System and obtained regulatory approval from India's CDSCO to initiate a 102-patient clinical trial with Shalby Limited. The trial will demonstrate fully autonomous, hands-free, saw-based robotic total knee surgeries on live patients, expected to begin within 90 business days.Financial highlights for Q1 2025 include: R&D expenses decreased 6% to $2.3M, marketing expenses dropped 63% to $44,000, and G&A expenses were $1.0M. The company reported a net loss of $3.2M, improving from $3.5M in Q1 2024. Cash and equivalents stood at $13.3M as of March 31, 2025.

#MGRM Monogram Technologies Reports First Quarter 2025 Financial Results

www.stocktitan.net/news/MGRM/monogram-techn...

CORRECTION FROM SOURCE: Monogram Technologies Receives Regulatory Approval to Start Clinical Trials in India Monogram Granted Regulatory Approval to Import mBôs TKA System for Clinical InvestigationPatient Enrollment will Begin Shortly; First Live Patient Surgeries are Anticipated within 90 Business DaysCritical Milestone Achieved for Multi-Center Clinical Trial in India with Strategic Partner Shalby

#MGRM CORRECTION FROM SOURCE: Monogram Technologies Receives Regulatory Approval to Start Clinical Trials in India

www.stocktitan.net/news/MGRM/correction-fro...

Monogram Technologies Granted Regulatory Approval to Import mBôs TKA System for Clinical Investigation in India Patient Enrollment will Begin Shortly; First Live Patient Surgeries are Anticipated within 90 Business DaysCritical Milestone Achieved for Multi-Center Clinical Trial in India with Strategic Partner Shalby Hospitals for the mBȏs TKA System AUSTIN, TEXAS / ACCESS Newswire / April 29, 2025 / Monogram

#MGRM Monogram Technologies Granted Regulatory Approval to Import mBôs TKA System for Clinical Investigation in India

www.stocktitan.net/news/MGRM/monogram-techn...

#MGRM: Monogram Receives Clearance from the FDA on its 510(k) Submission for its mBôs TKA System. buff.ly/5gdjdzu

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

Most searched small-cap stocks, Mon Mar 17th - #CIFR #WOLF #RXRX #NGD #JBLU #LAES #VRN #CLSK #$WULF #MGRM #NAOV #BBAI #IQ #UUUU #UEC #RGTI #QUBT #QBTS #GOOS #APLD - More: crystalequityresearch.com/SmCpStr/ - #smallcap

FDA Greenlights Monogram's Revolutionary Robotic Knee Surgery Platform - What Sets It Apart Monogram's mBôs TKA System receives FDA 510(k) clearance, advancing robotic-assisted knee surgery with enhanced safety and precision. Strategic rollout planned with KOL surgeons.

#MGRM Monogram Technologies Announces FDA 510(k) Clearance for the Monogram mBôsTM TKA System

www.stocktitan.net/news/MGRM/monogram-techn...

#MGRM: Monogram Technologies Reports 4th Quarter and Full Year 2024 Results buff.ly/zBBx2No

Monogram Technologies Raises $13M as Executives Buy $1M in Stock Monogram Tech strengthens position with oversubscribed offering, completes FDA submission for mBȏs™ TKA System. Management shows confidence through $1M stock purchase.

#MGRM Monogram Technologies Reports Full Year 2024 Financial Results

www.stocktitan.net/news/MGRM/monogram-techn...

#MGRM: Monogram’s Potential for 2025 Commercialization of its mBôs Total Knee Arthroplasty Robotic System Supports Price Target of $6.00 #medtech #orthopedics #technology

Read the full article here: buff.ly/QQhrms4

#MGRM: Monogram’s Potential for 2025 Commercialization of its mBôs Total Knee Arthroplasty Robotic System Supports Price Target of $6.00. buff.ly/4h3l3fJ

Can Monogram's Enhanced Robotic Knee System Disrupt Orthopedic Surgery After FDA Response? Monogram completes FDA submission with 300% faster cutting system while preparing multicenter clinical trials in India with Shalby and Reliance Life Sciences.

#MGRM Monogram Technologies Provides Regulatory Update on mBôs TKA System and Clinical Trial Preparation in India

www.stocktitan.net/news/MGRM/monogram-techn...

Monogram Tech Advances FDA Clearance Path for Robotic Surgery System, Plans Q1 2025 Response Monogram Technologies reports progress on FDA clearance for its mBôs TKA surgical robot, expecting to address regulatory requirements without clinical trials. Key expansion plans underway.

#MGRM Monogram Technologies Provides 510(k) Submission Update Following Positive Meeting with FDA

www.stocktitan.net/news/MGRM/monogram-techn...

Monogram Tech Execs Buy $1M in Stock, Set Key FDA and Global Expansion Milestones | MGRM Stock News Monogram Technologies' management invests $1M in company stock as CEO signals confidence. Key developments include FDA meetings, India trials, and global partnerships.

#MGRM Monogram Technologies Announces Management and Related Parties Complete Open Market Purchases of MGRM Common Stock Totaling $1 Million

#news #stocks #investing

www.stocktitan.net/news/MGRM/monogram-techn...

#MGRM Monogram Technologies Reports Third Quarter 2024 Financial Results

www.stocktitan.net/news/MGRM/monogram-techn...